Prescriber License Risk & Payer Audit Exposure in Specialty & Infusion Pharmacy
MedEdge Solutions releases its first public intelligence resource on prescriber license risk and payer audit exposure in specialty and infusion pharmacy. Free. Public. No registration required.
The Payer Audit Environment Changed Permanently. Here's the Intelligence You Need to Navigate It.
For Immediate Distribution — April 2026
MedEdge Solutions, the data intelligence authority in infusion and specialty pharmacy, today released its inaugural public intelligence resource: Prescriber License Risk & Payer Audit Exposure in Specialty & Infusion Pharmacy.
Published by the MedEdge Educational Team and released free of charge with no registration requirement, this resource represents the most comprehensive publicly available analysis of prescriber license disciplinary trends, payer audit escalation mechanics, and pharmacy recoupment exposure in the specialty and infusion sector.
Released ahead of NHIA's Annual Conference, MedEdge is positioning this as the defining intelligence resource for pharmacy operators navigating what the data identifies as a permanent structural shift in the payer enforcement landscape.
Why This Matters Now
Payer and PBM audit activity reached unprecedented levels in 2024 and 2025. Independent legal sources confirm that PBMs dramatically increased audit volume, tightened documentation standards, and initiated network terminations based solely on audit findings. For specialty and infusion pharmacies dispensing high-cost biologics, oncology drugs, and infusion therapies, the financial exposure is no longer theoretical.
Most pharmacies believe that a valid NPI confirms their prescriber is currently licensed. It does not. The NPI Registry is an identification database, not a licensure database. A physician can hold a valid, active NPI and a simultaneously revoked state license. Payers know this distinction. Their auditors exploit it.
This resource exists to close that knowledge gap — and to equip pharmacy operators with the full intelligence picture before the next audit letter arrives.
What This Resource Documents
Rising Disciplinary Action Trends
5,600+ physician disciplinary actions recorded in 2023 alone — a 14% increase from pre-pandemic levels, with trajectory projections through 2024 and beyond. Breakdown by violation category, specialty, and geographic concentration.
The NPI Misconception
A detailed analysis of why the most common prescriber verification method used by specialty pharmacies today provides no contractual protection against payer recoupment — and why payer auditors are counting on that gap.
Payer Audit Escalation — The Evidence and the Forecast
Five structural forces driving audit escalation through 2026–2028. None are cyclical. All are accelerating. Documented confirmation from independent legal and industry sources published in 2024 and 2025.
The Real Financial Exposure
Scenario modeling across prescriber categories and claim volumes — from $160,000 in single-prescriber oral specialty exposure to $4.25M+ in hub program systemic gaps. What the numbers actually look like for a pharmacy dispensing $5M–$20M annually in specialty claims.
The Verification Gap
A database latency analysis documenting the window between when a disciplinary action is taken and when it appears in searchable databases — and what that window costs pharmacies filling high-value claims during that period.
A Prioritized Action Framework
What to do in the next 30, 60, and 90 days. Immediate actions, near-term implementation, and long-term strategic infrastructure — sequenced for pharmacy operators who need to move now.
"The specialty and infusion pharmacy industry has treated prescriber license verification as a credentialing formality for too long. The audit environment has fundamentally and permanently changed. This resource exists because pharmacy operators deserve the full intelligence picture — not a vendor pitch, not a compliance checklist, but a rigorous analysis of what is actually happening and what is coming."
— Jon Love, President & Chief Growth Officer
Who This Resource Is For
This intelligence resource was written for owners, COOs, directors, and VP-level operators of specialty and infusion pharmacy organizations. It is equally relevant for compliance officers, revenue cycle leaders, payer relations teams, and healthcare legal counsel advising pharmacy clients.
Distribution with attribution is encouraged. MedEdge welcomes public comment, data submissions, and collaborative research on prescriber license integrity and payer audit trends.
MedEdge at Asembia
The MedEdge team will be present at Asembia's AXS2026 Summit and available for strategic discussions throughout the week. This intelligence resource will serve as the foundation for conversations we are having with pharmacy operators, compliance leaders, and executive teams on the floor.
If you want to sit down and talk through what the audit environment means for your organization specifically — before a payer finds the gap first — reach out now and let's get time on the calendar.
👉Book a Strategy Session with our team at Asembia
Access the Full Intelligence Resource
Free. Public. No registration required. Released for distribution with attribution.
©Copyright | Interior 2020. All Right Reserved